| Literature DB >> 36082085 |
Yoshiki Chiba1, Masahiro Miyajima1, Yoshiaki Takase1, Kodai Tsuruta1, Yuma Shindo1, Yasuyuki Nakamura1, Daichi Ishii1, Taiki Sato1, Miho Aoyagi1, Tomoko Shiraishi2, Tomoko Sonoda3, Atsushi Watanabe1.
Abstract
Background: Minimally invasive surgery is the standard treatment for early-stage thymoma. We compared the perioperative outcomes between robot-assisted thoracoscopic surgery (RATS) and video-assisted thoracoscopic surgery (VATS) for thymoma.Entities:
Keywords: Inverse probability of treatment weighting (IPTW); postoperative quality of life (postoperative QOL); robot-assisted thoracoscopic surgery (RATS); thymoma; video-assisted thoracoscopic surgery (VATS)
Year: 2022 PMID: 36082085 PMCID: PMC9445717 DOI: 10.21037/gs-22-333
Source DB: PubMed Journal: Gland Surg ISSN: 2227-684X
Figure 1Patient flow chart with the inclusion and exclusion criteria. MIS, minimally invasive surgery; RATS, robot-assisted thoracoscopic surgery; VATS, video-assisted thoracoscopic surgery.
The nursing care systems: nursing dependency score and nursing criteria
| Nursing care systems | Content |
|---|---|
| Nursing dependency score | |
| Turning over while sleeping in bed | |
| 0 point | Possible |
| 1 point | Possible if you hold on to something |
| 2 point | Impossible |
| Transferring | |
| 0 point | Possible |
| 1 point | Possible with some assistance |
| 2 point | Requiring full assistance |
| Intraoral cleaning | |
| 0 point | Possible |
| 1 point | Requiring assistance |
| 2 point | – |
| Food intake | |
| 0 point | Possible |
| 1 point | Possible with some assistance |
| 2 point | Requiring full assistance |
| Dressing and undressing | |
| 0 point | Possible |
| 1 point | Possible with some assistance |
| 2 point | Requiring full assistance |
| Understanding of medical instructions | |
| 0 point | Yes |
| 1 point | No |
| 2 point | – |
| Dangerous behavior | |
| 0 point | No |
| 1 point | – |
| 2 point | Yes |
| Nursing criteria | |
| Need for nursing observation | |
| A | Requires constant observation |
| B | Requires intermittent observation (about every 1–2 weeks) |
| C | No need for intermittent observation |
| Freedom of life | |
| I | Always lying in bed |
| II | Able to sit up in bed by themselves |
| III | Able to walk in the hospital |
| IV | Almost no inconvenience in daily life |
Improvement in postoperative QOL was presented as the durations required to achieve a B item of fewer than 3 points (B duration) and to achieve nursing criterion CIII (CIII duration), based on the Nursing Dependency Score and Nursing Criteria, respectively. QOL, quality of life.
Figure 2Surgical position and port placements. (A) Left semi-decubitus positioning of the patient with the ipsilateral arm positioned backward; (B) robotic 8-mm ports placed in the second, fourth, sixth, and seventh intercostal space and an assistant port with a 12-mm air seal port placed in the sixth intercostal space.
Comparison of patient characteristics between the RATS and VATS groups before and after IPTW adjustment
| Characteristics | Before IPTW adjustment | After IPTW adjustment | |||||
|---|---|---|---|---|---|---|---|
| RATS (n=20) | VATS (n=37) | P value | RATS (n=20) | VATS (n=37) | P value | ||
| Age (years) | 55 (34 to 88) | 61 (30 to 82) | 0.646 | 55 (34 to 88) | 61 (30 to 82) | 0.651 | |
| Male/female (male) | 7/13 (35.0) | 16/21 (43.2) | 0.585 | 33.5 | 41.6 | 0.390 | |
| Body height (cm) | 159 (148 to 187) | 162 (149 to 186) | 0.900 | 159 (148 to 187) | 162 (149 to 186) | 0.907 | |
| Body mass index (kg/m2) | 24.1 (17.7 to 31.2) | 23.4 (16.0 to 32.7) | 0.676 | 24.1 (17.7 to 31.2) | 23.4 (16.0 to 32.7) | 0.682 | |
| Performance status 0–1 | 20 | 37 | – | 100 | 100 | – | |
| Comorbidities | |||||||
| Cardiovascular disease | 1 (5.0) | 2 (5.4) | 1.000 | 2.5 | 3.8 | 1.000 | |
| Diabetes mellitus | 3 (15.0) | 7 (18.9) | 1.000 | 21.2 | 20.9 | 0.804 | |
| Myasthenia gravis | 4 (20.0) | 11 (29.7) | 0.182 | 16.1 | 23.5 | 0.310 | |
| Use of antithrombotics | 2 (10.0) | 5 (13.5) | 1.000 | 4.9 | 9.5 | 0.695 | |
| Smoker | 0.830 | 0.687 | |||||
| Never | 9 (45.0) | 15 (40.5) | 45.6 | 43.3 | |||
| Former | 3 (15.0) | 8 (21.6) | 10.4 | 16.6 | |||
| Current | 8 (40.0) | 14 (37.8) | 44.1 | 40.1 | |||
| Tumor size (mm) | 33.5 (9 to 65) | 33 (9 to 70) | 0.442 | 33.5 (9 to 65) | 33 (9 to 70) | 0.447 | |
| Operative procedure | 0.286 | 0.132 | |||||
| Extended thymectomy | 6 (30.0) | 14 (37.8) | 33.3 | 35 | |||
| Thymectomy | 14 (70.0) | 20 (54.1) | 66.7 | 59.4 | |||
| Partial thymectomy | 0 | 3 (8.1) | 0 | 5.7 | |||
| Combined resection | 2 (10.0) | 4 (10.8) | 1.000 | 8.9 | 10.7 | 0.727 | |
| Approach side | 0.281 | 0.178 | |||||
| Right | 16 (80.0) | 28 (75.7) | 84.7 | 74.7 | |||
| Left | 4 (20.0) | 5 (13.5) | 15.3 | 17.7 | |||
| Bilateral | 0 | 4 (10.8) | 0 | 7.6 | |||
| Adhesion | 0.267 | 0.682 | |||||
| None | 13 (65.0) | 31 (83.8) | 78.8 | 85.5 | |||
| Mild | 5 (25.0) | 4 (10.8) | 13.4 | 8.5 | |||
| Moderate | 2 (10.0) | 2 (5.4) | 7.8 | 6 | |||
| Insufflation of carbon dioxide | 20 | 4 (10.8) | <0.001 | 100 | 14.2 | <0.001 | |
| Masaoka stages | 0.633 | 0.395 | |||||
| I | 10 (50.0) | 21 (56.8) | 52.5 | 54.2 | |||
| II | 10 (50.0) | 15 (40.5) | 47.5 | 41.7 | |||
| III/IV | 0/0 | 1 (2.7)/0 | 0/0 | 4.1/0 | |||
| TNM classification | |||||||
| T | 1.000 | 0.504 | |||||
| 1 | 20 (100.0) | 36 (97.3) | 100 | 95.9 | |||
| 2 | 0 | 1 (2.7) | 0 | 4.1 | |||
| N | 0 | 0 | – | 0 | 0 | – | |
| M | 0 | 0 | – | 0 | 0 | – | |
| Stage 1/2 | 20/0 | 36 (97.3)/1 (1.8) | 1.000 | 100.0/0 | 95.9/4.1 | 0.504 | |
| WHO | 0.923 | 0.284 | |||||
| A | 2 (10.0) | 4 (10.8) | 9.7 | 10 | |||
| AB | 7 (35.0) | 12 (32.4) | 30.5 | 28.9 | |||
| B1 | 5 (25.0) | 10 (27.0) | 22.4 | 35.7 | |||
| B2 | 5 (25.0) | 7 (18.9) | 33.8 | 16.5 | |||
| B3 | 1 (5.0) | 4 (10.8) | 3.6 | 8.9 | |||
| Adjuvant chemotherapy | 0 | 0 | – | 0 | 0 | – | |
| Adjuvant radiotherapy | 4 (20.0) | 7 (18.9) | 1.000 | 11.9 | 18.2 | 0.410 | |
Continuous data are presented as the median and interquartile range in brackets, and categorical data are presented as n (%) before IPTW adjustment, while as only % after IPTW adjustment. RATS, robot-assisted thoracoscopic surgery; VATS, video-assisted thoracoscopic surgery; IPTW, inverse probability of treatment weighting; TNM, tumor node metastasis; WHO, World Health Organization.
Details of port placement, incision, and chest tube
| Variables | Before IPTW adjustment | After IPTW adjustment | |||||
|---|---|---|---|---|---|---|---|
| RATS (n=20) | VATS (n=37) | P value | RATS (n=20) | VATS (n=37) | P value | ||
| No. of ports | <0.001 | <0.001 | |||||
| 1–3 | 2 (10.0) | 33 (89.2) | 12.2 | 92.5 | |||
| 4–6 | 18 (90.0) | 4 (10.8) | 87.8 | 7.5 | |||
| Assistant port | 19 (95.0) | 26 (70.3) | 0.041 | 96.8 | 74.6 | 0.003 | |
| Mini-thoracotomy | 7 (35.0) | 35 (94.6) | <0.001 | 31.9 | 93.6 | <0.001 | |
| Max incision (mm) | 12 (8 to 40) | 35 (11 to 45) | <0.001 | 12 (8 to 40) | 35 (11 to 45) | <0.001 | |
| Max port incision (mm) | 12 (8 to 12) | 15 (11 to 20) | <0.001 | 12 (8 to 12) | 15 (11 to 20) | <0.001 | |
| No. of intercostal spaces | <0.001 | <0.001 | |||||
| <4 | 6 (30.0) | 34 (91.9) | 26.8 | 92.5 | |||
| 4–6 | 14 (70.0) | 3 (8.1) | 73.2 | 7.5 | |||
| No. of chest tubes | 1.000 | 0.504 | |||||
| 1 | 20 | 36 (97.3) | 100.0 | 95.9 | |||
| 2 | 0 | 1 (2.7) | 0 | 4.1 | |||
Continuous data are presented as the median and interquartile range in brackets, and categorical data are presented as n (%) before IPTW adjustment, while as only % after IPTW adjustment. IPTW, inverse probability of treatment weighting; RATS, robot-assisted thoracoscopic surgery; VATS, video-assisted thoracoscopic surgery.
Comparisons of surgical outcomes and postoperative pain between RATS and VATS before and after IPTW adjustment
| Variables | Before IPTW adjustment | After IPTW adjustment | |||||
|---|---|---|---|---|---|---|---|
| RATS (n=20) | VATS (n=37) | P value | RATS (n=20) | VATS (n=37) | P value | ||
| Primary outcomes | |||||||
| B duration (days)a | 2 (1 to 4) | 3 (1 to 7) | <0.001 | 2 (1 to 4) | 3 (1 to 7) | <0.001 | |
| CIII duration (days)a | 3 (1 to 6) | 5 (1 to 14) | 0.018 | 3 (1 to 6) | 5 (1 to 14) | 0.037 | |
| Secondary outcomes | |||||||
| Operation time (minutes) | 176 (103 to 285) | 143 (68 to 385) | 0.024 | 176 (103 to 285) | 143 (68 to 385) | 0.025 | |
| Intraoperative bleeding (mL) | 10 (5 to 100) | 10 (5 to 390) | 0.328 | 10 (5 to 100) | 10 (5 to 390) | 0.332 | |
| Pleural drainage duration (days) | 1 (1 to 2) | 1 (1 to 6) | 0.065 | 1 (1 to 2) | 1 (1 to 6) | 0.067 | |
| Postoperative pleural drainage (mL/kg/day) | 3.3 (0.4 to 8.0) | 4.3 (1.0 to 9.9) | 0.707 | 3.3 (0.4 to 8.0) | 4.3 (1.0 to 9.9) | 0.713 | |
| Removal of oxygen (days) | 1 (1 to 8) | 1 (1 to 7) | 0.310 | 1 (1 to 8) | 1 (1 to 7) | 0.315 | |
| Removal of urinary balloon catheter (days) | 1 (1 to 2) | 1 (1 to 3) | 0.503 | 1 (1 to 2) | 1 (1 to 3) | 0.511 | |
| Postoperative hospital stay (days) | 8 (2 to 14) | 8 (2 to 18) | 0.407 | 8 (2 to 14) | 8 (2 to 18) | 0.412 | |
| Total complications | 4 (20.0) | 8 (21.6) | 1.000 | 20.7 | 18.5 | 0.599 | |
| Phrenic nerve palsy | 3 (15.0) | 3 (8.1) | 0.657 | 13.4 | 6.6 | 0.458 | |
| Intercostal neuralgia | 1 (5.0) | 2 (5.4) | 1.000 | 7.3 | 4.6 | 1.000 | |
| Pneumothorax | 0 | 1 (2.7) | 1.000 | 0 | 1.9 | 1.000 | |
| Atrial fibrillation | 0 | 1 (2.7) | 1.000 | 0 | 1.9 | 1.000 | |
| Disrupted wound healing | 0 | 1 (2.7) | 1.000 | 0 | 3.4 | 1.000 | |
| Myasthenic crisis | 0 | 0 | – | 0 | 0 | – | |
| Mortality (30-day) | 0 | 0 | – | 0 | 0 | – | |
| Mortality (90-day) | 0 | 0 | – | 0 | 0 | – | |
| Postoperative pain | |||||||
| During hospitalization | |||||||
| Epidural analgesia | 20 | 30 | 0.045 | 100 | 84.9 | 0.018 | |
| Removal of epidural anesthesia | 2 (1 to 4) | 2 (1 to 4) | 0.144 | 2 (1 to 4) | 2 (1 to 4) | 0.146 | |
| No. of injections of analgesics | 2 (0 to 4) | 2 (1 to 5) | 0.577 | 2 (0 to 4) | 2 (1 to 5) | 0.583 | |
| Additional regular prescription | 2 | 10 | 0.182 | 14.1 | 35.5 | 0.033 | |
| Prescription as needed | 4 | 9 | 1.000 | 10.6 | 28.4 | 0.035 | |
| In the first follow-up | |||||||
| Duration (days) | 25 (12 to 37) | 22 (12 to 97) | 0.085 | 25 (12 to 37) | 22 (12 to 97) | 0.087 | |
| Pain gradeb | 0.885 | 0.376 | |||||
| 1 | 10 (50.0) | 19 (51.4) | 38.9 | 45.5 | |||
| 2 | 9 (45.0) | 15 (40.5) | 52.4 | 39.1 | |||
| 3 | 1 (5.0) | 3 (8.1) | 8.7 | 15.5 | |||
| Prescription | 10 (52.6) | 17 (46.0) | 0.779 | 53.99 | 51.5 | 0.812 | |
| In the second follow-up | |||||||
| Duration (days) | 92 (22 to 214) | 116 (48 to 389) | 0.267 | 92 (22 to 214) | 116 (48 to 389) | 0.272 | |
| Pain gradeb | 0.700 | 0.109 | |||||
| 1 | 18 (90.0) | 32 (86.5) | 86.9 | 84.0 | |||
| 2 | 1 (5.0) | 4 (10.8) | 4.4 | 14.1 | |||
| 3 | 1 (5.0) | 1 (2.7) | 8.7 | 4.9 | |||
| Prescription | 2 (10.5) | 4 (10.8) | 1.000 | 13.8 | 10.4 | 1.000 | |
Continuous data are presented as the median and interquartile range in brackets, and categorical data are presented as n (%) before IPTW adjustment, while as only % after IPTW adjustment. a, improvement in postoperative QOL was presented as the durations required to achieve a B item of fewer than 3 points (B duration) and to achieve nursing criterion CIII (CIII duration), based on the Nursing Dependency Score and Nursing Criteria, respectively; b, pain grade was defined as follows: 1. no pain or pain not requiring analgesics; 2. pain requiring analgesics (excluding those for neuralgia); 3. pain requiring analgesics for neuralgia. RATS, robot-assisted thoracoscopic surgery; VATS, video-assisted thoracoscopic surgery; IPTW, inverse probability of treatment weighting; QOL, quality of life.
Figure 3Multivariable logistic regression analysis of surgical outcomes and postoperative pain after the IPTW adjustment according to surgical approach (VATS group, OR 1). ◆: OR; −: 95% CI. a, improvement in postoperative QOL was presented as the durations required to achieve a B item of fewer than 3 points (B duration) and to achieve nursing criterion CIII (CIII duration), based on the Nursing Dependency Score and Nursing Criteria, respectively; b, pain grade was defined as follows: 1. no pain or pain not requiring analgesics; 2. pain requiring analgesics (excluding those for neuralgia); 3. pain requiring analgesics for neuralgia. CI, confidence interval; OR, odds ratio; RATS, robot-assisted thoracoscopic surgery; VATS, video-assisted thoracoscopic surgery; IPTW, inverse probability of treatment weighting; QOL, quality of life.
Multivariable logistic regression analysis of factors associated with the Nursing Dependency Score and Nursing Criteria for all patients after IPTW adjustment
| Variables | OR | 95% CI | P value |
|---|---|---|---|
| B durationa | |||
| Operative procedure | |||
| Extended thymectomy | 10.07 | 0.77–131.25 | 0.078 |
| Thymectomy (including partial) | 1.00 | ||
| Approach side | |||
| Bilateral | 1.56 | 0.11–21.8 | 0.743 |
| Unilateral | 1.00 | ||
| Pleural drainage duration | 73.48 | 9.94–543.11 | <0.001 |
| Epidural analgesia | 0.81 | 0.01–55.5 | 0.923 |
| Additional regular prescription | 0.60 | 0.07–5.09 | 0.640 |
| Prescription as needed | 0.58 | 0.06–5.96 | 0.643 |
| CIII durationa | |||
| Operative procedure | |||
| Extended thymectomy | 1.53 | 0.56–4.16 | 0.408 |
| Thymectomy (including partial) | 1.00 | ||
| Approach side | |||
| Bilateral | 5.10 | 0.79–32.96 | 0.087 |
| Unilateral | 1.00 | ||
| Pleural drainage duration | 13.40 | 2.36–76.92 | 0.004 |
| Epidural analgesia | 0.70 | 0.13–3.80 | 0.678 |
| Additional regular prescription | 0.58 | 0.20–1.70 | 0.324 |
| Prescription as needed | 0.48 | 0.15–1.46 | 0.195 |
a, improvement in postoperative QOL was presented as the durations required to achieve a B item of fewer than 3 points (B duration) and to achieve nursing criterion CIII (CIII duration), based on the Nursing Dependency Score and Nursing Criteria, respectively. IPTW, inverse probability of treatment weighting; OR, odds ratio; CI, confidence interval; QOL, quality of life.